Navigation Links
Intensive summer program helps physicians build clinical research careers
Date:3/24/2009

evention and treatment," says study co-author Daniel E. Singer, MD, associate director of the PCE and director of the General Medicine Fellowship at MGH. "Information generated from clinical trials is often not widely applied to producing safer and more effective medical care. Physician-researchers knowledgeable about biology, clinical medicine and population health who are trained in rigorous research methods are essential to conduct the studies needed to speed translation of knowledge into beneficial medical and public health advances."

Established in 1986, the PCE is an intensive six-and-a-half week summer program based at HSPH that includes core courses in epidemiology and biostatistics along with electives. The epidemiology course requires students to prepare and submit a grant proposal as the final course project, and several electives have added a similar requirement in recent years. Many participants have gone on to pursue advanced degrees after completing the PCE. Most of the almost 1,500 physicians who completed the program during its first two decades enrolled during their post-residency fellowship training.

The Academic Medicine paper describes results of a 20th anniversary survey sent to all PCE graduates in 2006. The survey was designed to evaluate graduates' success and identify features predicting who would achieve successful NIH funding. Among the almost 1,000 graduates responding to the survey, 65 percent indicated that their epidemiology grant proposal led to an actual research project; and of those studies, 64 percent were published and 43 percent received funding. In recent years, real-world projects applying course concepts have been required for completion of elective courses, which led to published studies for 30 percent of all graduates, 14 percent of whom received funding for the projects.

Overall, 34 percent of survey respondents reported receiving NIH support, and 63 percent received support from nonf
'/>"/>

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. NICE SUGAR: Intensive insulin therapy risks
2. Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26
3. New Anxiety and Mood Disorders Intensive Treatment Program in Downtown Chicago
4. Intensive Resource Group (IRG) Helps Hospitals Address Financial and Operational Crisis
5. Intensive Insulin Therapy Reduces Mortality in Sick Kids
6. Intensive support programs can help hospitalized smokers stay smoke-free
7. Integrated Medical Systems Receives FDA Clearance for Worlds First Suitcase Intensive Care Unit
8. New Intensive Care Unit at Gilbert Hospital Sees First Patient
9. WellPoint Partners With CareNex Health Services to Expand Its Neonatal Intensive Care Services Program
10. Newborns in Intensive Care Often Exposed to Pain
11. Less Intensive Treatment Given Diabetic Women With Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... (PRWEB) May 23, 2013 As Stryker ... Rejuvenate and ABG II Modular-Neck Hip Stems continue to mount ... new research has found a connection between the type of ... The study, which was published on May 15th in ... hips in 11 patients who reported new-onset and increasing ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Diabetes is ... it can become a nuisance when patients are unfortunate ... According to the National Diabetes Information Clearinghouse at ... at a risk of developing neuropathy which further shrivels ... lives of such patients. Such nerve damage affects the ...
(Date:5/23/2013)... SLEEPY HOLLOW, NY (PRWEB) May 23, 2013 ... joined the staff of Phelps Memorial Hospital Center as ... She will direct comprehensive inpatient and outpatient rehabilitation ... life. , Dr. Liu received her undergraduate degree in ... Scholar for four years. She earned her medical ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- Statins are proven ... the medications also could hamper heart patients, ability to ... A small group of overweight or obese people were ... a 40 milligram daily dose of simvastatin, while another ... exercise regimen did show improvement, found the study released ...
(Date:5/23/2013)... (May 23, 2013) -- Little is known about why ... response to treatments varies between patients. Now, a team ... Medical Center and SUNY Downstate Medical Center has revealed ... showing that it is very different from other asthma ... , reveals that an over-active gene linked in 20 ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 2Health News:Stryker Hip Lawsuit News: Bernstein Liebhard LLP Comments on Research Linking Femoral Stem Corrosion at Modular-Neck Junction with Local Soft Tissue Destruction 3Health News:Neuropathy Nerve Damage Can Now Be Reversed With Neuracel 2Health News:Wei Angela Liu, MD, Named Head of Physical Medicine and Rehabilitation at Phelps Memorial Hospital Center in Sleepy Hollow, New York 2Health News:Statins May Hamper Workout Results 2Health News:Statins May Hamper Workout Results 3Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 2Health News:Researchers find common childhood asthma unconnected to allergens or inflammation 3
... Johna Burke will describe communication tactics that can ... delivered on Tuesday, Jan. 6, at a professional ... of the International Association of Business Communicators (IABC). ... website ( www.sc-iabc.com ) or from Stefanie Caraviello ...
... Care Action Network (SCAN(R)) Health Plan Arizona, a nonprofit Medicare ... to train more than 60 seasoned van drivers about what ... a senior." SCAN has been focused on the unique needs ... to enhancing awareness and skills in the community in dealing ...
... Calif., January 5, 2008Scientists at Burnham Institute for Medical ... protein kinase complex Cdc7/Dbf4 or Cdc7/Drf1 (Ddk) in monitoring ... DNA repair. Since Ddk is often deregulated in human ... damage control could help shape new cancer therapies. The ...
... 5, 2009 Only 17 percent of Spanish-speaking women ... a multivitamin containing folic acid daily, according to the ... on this population. , Folic acid can prevent ... brain and spine such as spina bifida and anencephaly, ...
... experts at the University of Cincinnati (UC) have identified a ... drug therapies to combat lung cancer. , The study, led ... of Molecular and Cellular Biology . , Proto-oncogenes ... (turnover of cells and tissue) but, when genetically modified, can ...
... ignition gadget prevents calls or texting while driving , , ... that prevents teens from talking on cell phones or ... of Utah researchers. , The Key2SafeDriving system includes ... connects wirelessly with the user,s cell phone via either ...
Cached Medicine News:Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 2Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 3Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 2Health News:SCAN Health Plan Arizona Helps Drivers Understand the Challenges of Aging 3Health News:Burnham researchers illuminate mechanisms that regulate DNA damage control and replication 2Health News:Folic acid survey of Spanish-speaking women finds most are missing benefits, March of Dimes says 2Health News:Cell biologists identify new tumor suppressor for lung cancer 2Health News:Car Key Device Jams Teens' Cell Phones 2
(Date:5/22/2013)... , May 22, 2013 Advanced Prenatal ... medical device that will help alleviate the high blood ... apheresis cartridge is expected to be the first medical ... of maternal and fetal death. Every year, ... the United States . It is characterized by ...
(Date:5/22/2013)... , May 22, 2013 Attorney ... potential claims on behalf of purchasers of the ... "Company") (NasdaqGS: AMAG -News).  The investigation focuses on ... securities laws. On May 22, 2013, ... intraday trading after the company announced in regulatory ...
(Date:5/22/2013)... May 22, 2013  The Leukemia & Lymphoma Society ... Valor Biotherapeutics, LLC, a joint venture between ImmunGene and ... and a Phase I clinical trial for a novel ... by many patients with indolent lymphomas who do not ... Valor,s protein, IGN002, is a new class of biotherapeutics ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... Yesterday, T he Lancet published online the ... Victoza® (liraglutide [rDNA] injection) with a DPP-4 inhibitor, Januvia®.  The 26-week ... plasma glucose (FPG), and body weight than Januvia®, with similar or ... , , ...
... April 23 Results of a ... g/d significantly improved lipid and glycemic measures in ... fasting glucose and/or impaired glucose tolerance).  The randomized, ... American Association of Clinical Endocrinologists (AACE) 19th Annual ...
Cached Medicine Technology:The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 2The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 3The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 4The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 5The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 2New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 3New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 4New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 5New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 6New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 7New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 8New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 9New Data Demonstrate Welchol(R) (colesevelam HCl) Significantly Improved Lipid and Glycemic Measures in Patients With High LDL Cholesterol and Prediabetes 10
Mx3000P instrument, desktop computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, HE...
Inquire...
... real-time PCR detection system offers an affordable ... fluorescent dyes such as FAM and SYBR ... the iCycler thermal cycler, offering superior features ... performance. The MyiQ real-time PCR detection system ...
... PRISM 7000 Sequence Detection System is ... detects and quantitates nucleic acid sequences. ... accumulated PCR product is made possible ... and application-specific software in a single ...
Medicine Products: